These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12610825)
21. The association between human leukocyte antigens (HLA) and cytoplasmic-antineutrophil cytoplasmic antibody (cANCA)-positive Wegener's granulomatosis in a Japanese population. Nakamaru Y; Maguchi S; Takizawa M; Fukuda S; Inuyama Y Rhinology; 1996 Sep; 34(3):163-5. PubMed ID: 8938886 [TBL] [Abstract][Full Text] [Related]
22. [Review article: Antineutrophil cytoplasmic antibody in small vessel vasculitis]. Nakano H; Ozaki S Rinsho Byori; 2010 May; 58(5):480-9. PubMed ID: 20560457 [TBL] [Abstract][Full Text] [Related]
23. Primary systemic vasculitis. Day C; Savage C Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579 [TBL] [Abstract][Full Text] [Related]
25. [Anti-neutrophil cytoplasmic antibodies (ANCA): major progress in the diagnosis of vasculitis]. Goldman M; Servais C; Lambermont M; Tielemans C; Lambrechts A; Mascart-Lemone F; Dupont E Rev Med Brux; 1992 Nov; 13(9):333-6. PubMed ID: 1361072 [TBL] [Abstract][Full Text] [Related]
26. Plasma exchange in the treatment of Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal limited vasculitis. Casian A; Jayne D Curr Opin Rheumatol; 2011 Jan; 23(1):12-7. PubMed ID: 21124082 [TBL] [Abstract][Full Text] [Related]
27. The association of HLA-DRB1 alleles with antineutrophil cytoplasmic antibody-associated systemic vasculitis in Chinese patients. Luo H; Chen M; Yang R; Xu PC; Zhao MH Hum Immunol; 2011 May; 72(5):422-5. PubMed ID: 21354458 [TBL] [Abstract][Full Text] [Related]
28. Outcome and prognostic factors during the course of primary small-vessel vasculitides. Pavone L; Grasselli C; Chierici E; Maggiore U; Garini G; Ronda N; Manganelli P; Pesci A; Rioda WT; Tumiati B; Pavesi G; Vaglio A; Buzio C; J Rheumatol; 2006 Jul; 33(7):1299-306. PubMed ID: 16783858 [TBL] [Abstract][Full Text] [Related]
32. HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome. Vaglio A; Martorana D; Maggiore U; Grasselli C; Zanetti A; Pesci A; Garini G; Manganelli P; Bottero P; Tumiati B; Sinico RA; Savi M; Buzio C; Neri TM; Arthritis Rheum; 2007 Sep; 56(9):3159-66. PubMed ID: 17763415 [TBL] [Abstract][Full Text] [Related]
33. Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. Reinhold-Keller E; Herlyn K; Wagner-Bastmeyer R; Gross WL Arthritis Rheum; 2005 Feb; 53(1):93-9. PubMed ID: 15696553 [TBL] [Abstract][Full Text] [Related]
34. [Wegener granulomatosis and microscopic polyangiitis. Diagnostic and clinical results in 54 patients with long-term follow-up]. Bolley R; Mistry-Burchardi N; Samtleben W Dtsch Med Wochenschr; 2000 Dec; 125(50):1519-25. PubMed ID: 11190761 [TBL] [Abstract][Full Text] [Related]
35. [Detection of antineutrophil cytoplasmic antibodies for the values of Wegener's granulomatosis diagnosis and activity judgment]. Zhang X; Jiang M; Chui J; Wang H; Ma J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):284-7. PubMed ID: 10453568 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: metaanalysis with a focus on antimyeloperoxidase antibodies. Choi HK; Liu S; Merkel PA; Colditz GA; Niles JL J Rheumatol; 2001 Jul; 28(7):1584-90. PubMed ID: 11469466 [TBL] [Abstract][Full Text] [Related]